封面
市場調查報告書
商品編碼
1198452

專業 PACS 市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Specialty Pacs Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,專業 PACS 市場預計將以 4.87% 的複合年增長率註冊。

COVID-19 大流行對市場的增長產生了重大影響。 根據 2021 年 4 月 NCBI 的一篇文章,在過去的幾十年裡,大多數放射科不得不處理圖像存檔和通信系統 (PACS) 等關鍵系統的意外停機。 在一項研究中,研究人員啟用了家庭使用的 PACS 工作站並評估了系統性能。 從那時起,制定了各種指南,並且一些研究中心已經使 PACS 工作站的無線適配器能夠在家中使用。 這些用於評估 PACS 的在家工作選項增加了對 PACS 的需求,並對研究市場的增長產生了積極影響。 此外,在大流行期間 PACS 的部署有所增加,領先的公司已經開始創新多種 PACS 模型以促進市場增長。 例如,2020 年 3 月,PACS 解決方案提供商 IMAGE Information Systems 推出了 www.disAIblecorona.com,為放射學界提供了一個收集和分享全球 COVID-19 病例、學習和抗擊疾病的場所。 因此,COVID-19 對市場的增長產生了重大影響。

推動所研究市場增長的主要因素是可視化的使用越來越多、IT 架構和成像模式的結合,以及 PACS 被各種醫學學科納入實踐。 例如,2021 年 12 月,AI 射線照相報告公司 Synapsica 將與 Wipro GE Healthcare 支持的醫療選項供應商 GenWorks Wellbeing 合作,將其 PACS 帶到印度各地的城市。 該公司的 Radiolens 放射學工作流程解決方案定期檢測有風險的高質量掃描,並為大多數典型模式進行初步研究。 這種分銷協議也促進了市場的增長。

在 NCBI 於 2021 年 7 月發表的一篇研究論文中,日常臨床工作無時無刻不在產生大量圖像數據,導致檔案庫的不斷擴大和構建大規模醫學圖像存儲庫的新方法不斷湧現。將在世界各地舉行。 此外,JAMA 於 2021 年 10 月發表的另一篇論文指出,PACS 在醫學影像領域的增長和進步的一個顯著加速因素是數據存儲成本的顯著下降。 因此,預計該成本的額外好處將促進所研究市場的增長。

其他因素包括人口老齡化、各種疾病發病率增加、專業化 PACS 的好處、政府促進引入醫療 IT 解決方案的政策、診斷影像投資的增加以及醫學影像的接受度提高在 IT 解決方案中,成像設備的使用增加預計將在預測期內推動市場增長。

特殊 PACS 市場趨勢

On-premise 專用 PACS 有望在專用 PACS 市場佔據最大市場份額

本地模型是傳統的軟件部署模型。 醫療機構和醫院主要更喜歡本地數據存儲來存儲和管理患者數據。 現場交付,也稱為內部部署模式,定義為供應商派遣合格員工到客戶現場開發和交付軟件的方法。 易於訪問是推動本地軟件解決方案增長的關鍵因素。 對於在多個國家/地區擁有遠程位置的全球企業,由於帶寬限制,訪問雲資源可能是一個挑戰。

根據 NCBI 於 2021 年 8 月發表的一篇文章,臨床醫生和放射科醫生主要依靠 PACS 進行圖像顯示和分析。 但是,在部署過程中學習新工具等效率低下,此用例的雲採用阻礙了新的學習。 因此,從 2021 年 8 月起,Amazon Web Services (AWS) 將提供 VNA 等本地醫療成像工作站。

此外,2022 年 5 月在 Springer 上發表的一篇文章指出,本地軟件是在物理辦公室內部部署和維護的,而不是託管在供應商提供的雲上。據說。 它們在公司監督下運行,系統和數據仍處於公司控制之下。 本地專門從事與現有業務系統的集成。 因此,與這種交付形式相關的安全性有望推動這一細分市場的增長。

此外,根據 Creo 在 2022 年 1 月更新的數據,非本地軟件通常意味著如果軟件本身已獲得許可,則軟件的整個實例駐留在組織和數據的前提下,額外的保護需要公司-購買許可證或要使用的軟件副本。

因此,由於上述因素,在本研究的預測期內,現場(場所)部分預計會增長。

北美有望在預測期內主導市場

由於患者數量增加和老年人口增加等因素,預計在預測期內,北美將保持其在專業 PACS 市場的主導地位。 此外,該地區慢性病的增加、圖像處理設備的技術進步、早期發現疾病的好處以及大公司進入該地區正在推動市場增長並確保在該地區的主導地位。成為一個因素。

此外,市場參與者的戰略舉措有望促進市場的增長。 2021 年 7 月,GE Healthcare 開發了名為 Edison True PACS 的下一代雲圖像存儲和通信系統 (PACS)。 它是目前在美國可用的診斷成像和工作流程解決方案。

此外,在國內,PACS的臨床應用也已經開始,因此需求不斷增加並推動了市場的增長。 例如,2021 年 11 月,Change Healthcare 宣布了其 Stratus Imaging PACS 的臨床可用性。 它是一種雲原生、零佔用空間的 PACS。 這個可擴展的雲原生平台被美國的 StatRad 使用。 這種 PACS 的推出將促進研究市場的增長。

此外,市場參與者為營銷、使用或開發新產品而採取的合併、收購和合作夥伴關係等戰略舉措也在推動市場增長。 例如,2022 年 4 月,皇家飛利浦公司和南卡羅來納州最大的非營利性醫療保健系統之一 PrismaHealth 宣布,該醫療保健系統將實現企業互操作性、標準化患者監測並改善患者護理。雙方簽訂了一項多年期協議,以推動企業成像解決方案的創新,以增強和改進臨床性能。 這種夥伴關係也促進了市場的增長。

因此,上述因素預計將在預測期內推動該地區所研究市場的增長。

專業 PACS 市場競爭對手分析

專業 PACS 市場競爭激烈,由幾家主要參與者組成。 在市場份額方面,幾家主要參與者目前佔據市場主導地位,一些知名參與者正在合作、收購和推出新產品以鞏固其在全球的市場地位。 目前主導市場的公司包括 IBM 公司、愛克發醫療保健公司、富士膠片控股公司(富士醫療系統公司)、西門子股份公司和飛利浦醫療保健公司。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 擴大成像設備的使用
    • 慢性病負擔加重
  • 市場製約因素
    • 數據安全和隱私問題
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:100 萬美元)

  • 按類型
    • 心血管 PACS
    • 用於骨科手術的 PACS
    • 腫瘤學 PACS
    • 其他類型
  • 按組件
    • 軟件
    • 服務
    • 硬件
  • 按開發
    • 本地 PACS
    • Web/雲類型專用 PACS
  • 最終用戶
    • 醫院
    • 診斷中心
    • 其他最終用戶
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Agfa Healthcare
    • Canon USA Inc.
    • Fujifilm Holdings Corporation(Fujifilm Medical Systems)
    • IBM Corporation
    • McKesson Corporation
    • Novarad
    • Philips Healthcare
    • Sectra AB
    • Siemens AG
    • Topcon Corporation

第7章 市場機會與今後動向

簡介目錄
Product Code: 68681

The specialty PACS market is anticipated to register a CAGR of 4.87% during the forecast period.

The COVID-19 pandemic had a significant impact on the growth of the market. An article published by NCBI in April 2021 stated that over the past few decades, most radiology departments had to deal with unplanned downtimes of their critical systems, such as the picture archiving and communication system (PACS). During a study, researchers enabled their PACS workstation for home use and evaluated system performance. After that, various guidelines were made, and following that, several research centers allowed wireless adapters for PACS workstations for use at home. This work-from-home option for PACS for evaluation purposes increased the demand for the same, thereby impacting the growth of the market studied positively. Moreover, the implementation of PACS increased during the pandemic, and major players started innovating several PACS models to boost the growth of the market. For instance, in March 2020, IMAGE Information Systems, a provider of PACS solutions, launched www.disAIblecorona.com to offer the radiology community a place to collect and share worldwide COVID-19 cases to learn and fight the disease. Thus COVID-19 had a significant impact on the growth of the market.

The significant factors for the growth of the market studied are the growing use of visualization, the collaborations between IT structures and imaging modalities, and diverse medical fields incorporating PACS in their practice. For instance, in December 2021, AI radiology reporting firm Synapsica partnered with GenWorks Well being, a healthcare options supplier backed by Wipro GE Healthcare, to deliver its PACS to cities across India. Its Radiolens radiology workflow resolution routinely detects dangerous high-quality scans and creates preliminary studies for most typical modalities. Such distribution agreements are also boosting the growth of the market.

A research article published by NCBI in July 2021 stated that large amounts of imaging data are constantly generated in daily clinical practice, leading to continuously expanding archives, and new progressive efforts are being made worldwide to build large-scale medical imaging repositories. Furthermore, another article published by JAMA in October 2021 stated that an important accelerator for the growth and advancements of PACS in medical imaging is the huge drop in the cost of data storage. Thus, this added advantage of cost is anticipated to boost the growth of the market studied.

Additionally, the growing elderly population, successive growth in the occurrence of different diseases, benefits affiliated with specialty PACS, government measures to boost the implementation of medical IT solutions, rise in investments in diagnostic imaging, increase in acceptance of medical imaging IT solutions, and the growing use of imaging equipment are likely to boost the growth of the market studied during the forecast period.

Specialty PACS Market Trends

On-premise Specialty PACS are Expected to Hold the Largest Market Share in the Specialty PACS Market

The on-site model is the traditional model of software implementation. Healthcare facilities and hospitals largely prefer on-premise data storage to store and manage patient data. Onsite delivery is often called on-premise mode and is defined as a way of software development and delivery when vendors send their qualified employees to the client's site. Accessibility is the major factor driving the growth of on-premise software solutions. Access to cloud resources can pose a challenge due to bandwidth constraints for global companies with remote sites in multiple countries.

An article published by NCBI in August 2021 stated that clinicians and radiologists mostly rely on PACS to view and analyze images. But if any added inefficiency, such as learning new tools, is needed at the time of implementation, then cloud adoption for this use case would be a blocker for new learning. Hence, Amazon Web Services (AWS) have been offering on-premise medical imaging workstations such as VNA since August 2021.

Additionally, an article published in Springer in May 2022 stated that on-premise software is deployed and maintained in-house at a physical office instead of hosted on a vendor-supplied cloud. These run under company supervision, while the systems and data remain under the company's control. On-premise mode of delivery allows specialized integration with other existing business systems. Thus, the security associated with the mode of delivery is expected to drive the growth of the segment.

Moreover, as per the data updated by Cleo in January 2022, non-premise software requires a license purchased by the enterprise or a copy of the software to use it because when the software itself is licensed, the entire instance of the software resides within an organization's premises, and there is generally greater protection of data.

Thus, owing to the above-mentioned factors, the on-site (premise) segment is expected to grow during the forecast period of the study.

North America is Expected to Dominate the Market During the Forecast Period

North America is expected to maintain its dominance in the specialty PACS market during the forecast period, owing to factors such as the growing patient pool and rising geriatric population. Furthermore, the rising prevalence of chronic diseases in the region, technological advancement in imaging modalities, early disease detection benefits, and the domicile presence of some key players in the region are driving the growth of the market and are responsible for ensuring dominance in the region.

Additionally, the strategic initiatives by market players are expected to contribute to the growth of the market. In July 2021, GE Healthcare developed a next-generation, cloud-based picture archive and communication system (PACS) named Edison True PACS. It is a diagnostic imaging and workflow solution that is currently available in the United States.

Furthermore, the initiation toward the clinical use of PACS in the country is also increasing the demand, thereby driving the growth of the market. For instance, in November 2021, Change Healthcare reported that Stratus Imaging PACS is in clinical use. It is a cloud-native, zero-footprint PACS. This scalable, cloud-native platform is used by StatRad in the United States. Such initiations in the use of the PACS also propel the growth of the market studied.

Additionally, the strategic initiatives taken by the market players, such as mergers, acquisitions, and partnerships for the marketing, usage, or development of new products, are also driving the growth of the market. For instance, in April 2022, Royal Philips and Prisma Health, one of South Carolina's largest non-profit healthcare systems, entered into a multi-year agreement to help the health system achieve enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance. Such partnerships are also boosting the growth of the market.

Thus the above-mentioned factors are expected to drive the growth of the market studied in the region during the forecast period.

Specialty PACS Market Competitor Analysis

The specialty PACS market is competitive and consists of a few major players. In terms of market share, some major players have been currently dominating the market, and some prominent players have been vigorously making collaborations, acquisitions, and launching new products with other companies to consolidate their market positions across the world. Some of the companies, which are currently dominating the market, are IBM Corporation, Agfa Healthcare, Fujifilm Holdings Corporation (Fujifilm Medical Systems), Siemens AG, and Philips Healthcare.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Use of Imaging Devices
    • 4.2.2 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Data Security and Privacy Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Cardiovascular PACS
    • 5.1.2 Orthopedic PACS
    • 5.1.3 Oncology PACS
    • 5.1.4 Other Types
  • 5.2 By Component
    • 5.2.1 Software
    • 5.2.2 Services
    • 5.2.3 Hardware
  • 5.3 By Development
    • 5.3.1 On-premise Specialty PACS
    • 5.3.2 Web/Cloud-based Specialty PACS
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Diagnostic Centers
    • 5.4.3 Other End Users
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agfa Healthcare
    • 6.1.2 Canon USA Inc.
    • 6.1.3 Fujifilm Holdings Corporation (Fujifilm Medical Systems)
    • 6.1.4 IBM Corporation
    • 6.1.5 McKesson Corporation
    • 6.1.6 Novarad
    • 6.1.7 Philips Healthcare
    • 6.1.8 Sectra AB
    • 6.1.9 Siemens AG
    • 6.1.10 Topcon Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS